<p>The number and percentage of included studies with each study characteristic is presented. Means are presented with standard deviations, and medians with interquartile ranges (IQR).</p
Background: The Australian Imaging, Biomarkers and Lifestyle (AIBL) flagship study of aging aimed to...
<p>Notes:</p><p><i>a</i> indicates time since Alzheimer’s disease was first diagnosed by a physician...
<p>Abbreviations: NI, no information; AD, Alzheimer's disease; SLOAD, sporadic late-onset Alzheimer'...
<p>All values are arithmetic means with standard deviations in parentheses, except for sex, smoker s...
a<p>WT, Wilcoxon rank-sum test, two-sided; FET, Fisher's exact test, two-sided; SD, standard deviati...
<p>NINCDS-ADRDA = National Institute of Neurological and Communicative Disorders and Stroke-Alzheime...
<p>Disease severity (as measured by ACE-R) enabled a median split of the patient cohort into very mi...
<p>Values shown in parentheses are standard deviation, except where noted in the column header. Abbr...
<p>Characteristics of healthy participants and patients with Alzheimer’s disease.</p
<p>Mean (standard deviation). MMSE, Mini-Mental State Examination; CDR, clinical dementia rating; NC...
Background: The Australian Imaging, Biomarkers and Lifestyle (AIBL) flagship study of aging aimed to...
<p>Values are mean ± standard deviation. For gender and APOE status, percentages per group are given...
*<p><i>p</i> value<0.05 was obtained by comparing LOAD cases and controls.</p><p>Abbreviations: LOAD...
Background: The Australian Imaging, Biomarkers and Lifestyle (AIBL) flagship study of aging aimed to...
Alzheimer’s disease (AD) is a progressive neurodegenerative sensitivity ranged from 70.9 % to 87.3 %...
Background: The Australian Imaging, Biomarkers and Lifestyle (AIBL) flagship study of aging aimed to...
<p>Notes:</p><p><i>a</i> indicates time since Alzheimer’s disease was first diagnosed by a physician...
<p>Abbreviations: NI, no information; AD, Alzheimer's disease; SLOAD, sporadic late-onset Alzheimer'...
<p>All values are arithmetic means with standard deviations in parentheses, except for sex, smoker s...
a<p>WT, Wilcoxon rank-sum test, two-sided; FET, Fisher's exact test, two-sided; SD, standard deviati...
<p>NINCDS-ADRDA = National Institute of Neurological and Communicative Disorders and Stroke-Alzheime...
<p>Disease severity (as measured by ACE-R) enabled a median split of the patient cohort into very mi...
<p>Values shown in parentheses are standard deviation, except where noted in the column header. Abbr...
<p>Characteristics of healthy participants and patients with Alzheimer’s disease.</p
<p>Mean (standard deviation). MMSE, Mini-Mental State Examination; CDR, clinical dementia rating; NC...
Background: The Australian Imaging, Biomarkers and Lifestyle (AIBL) flagship study of aging aimed to...
<p>Values are mean ± standard deviation. For gender and APOE status, percentages per group are given...
*<p><i>p</i> value<0.05 was obtained by comparing LOAD cases and controls.</p><p>Abbreviations: LOAD...
Background: The Australian Imaging, Biomarkers and Lifestyle (AIBL) flagship study of aging aimed to...
Alzheimer’s disease (AD) is a progressive neurodegenerative sensitivity ranged from 70.9 % to 87.3 %...
Background: The Australian Imaging, Biomarkers and Lifestyle (AIBL) flagship study of aging aimed to...
<p>Notes:</p><p><i>a</i> indicates time since Alzheimer’s disease was first diagnosed by a physician...
<p>Abbreviations: NI, no information; AD, Alzheimer's disease; SLOAD, sporadic late-onset Alzheimer'...